Glucose, VEGF-A, and diabetic complications.

[1]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[2]  D. Foreman,et al.  Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy , 1999, The British journal of ophthalmology.

[3]  P. Carmeliet,et al.  Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System , 1997, Annals of the New York Academy of Sciences.

[4]  A. Samii,et al.  Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats , 1999, Neuroscience Letters.

[5]  J. Styrud,et al.  Diabetic Embryopathy Studies With Animal and In Vitro Models , 1991, Diabetes.

[6]  Lois E. H. Smith,et al.  Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor , 1999, Nature Medicine.

[7]  M. Shibuya,et al.  Neuropilin-1 Is a Placenta Growth Factor-2 Receptor* , 1998, The Journal of Biological Chemistry.

[8]  Y. Hata,et al.  Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. , 1995, Ophthalmic research.

[9]  P. Campochiaro,et al.  Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina , 1999, Journal of cellular physiology.

[10]  P. Einat,et al.  Translation of Vascular Endothelial Growth Factor mRNA by Internal Ribosome Entry: Implications for Translation under Hypoxia , 1998, Molecular and Cellular Biology.

[11]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[12]  T. Buchanan,et al.  Pre-Conception Care of Diabetes, Congenital Malformations, and Spontaneous Abortions , 1996, Diabetes Care.

[13]  X. Gu,et al.  Modulation of VEGF production by pH and glucose in retinal Müller cells. , 1998, Current eye research.

[14]  M. Neeman,et al.  Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Semenza.  Transcriptional regulation by hypoxia-inducible factor 1 molecular mechanisms of oxygen homeostasis. , 1996, Trends in cardiovascular medicine.

[16]  A. Nagy,et al.  Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. , 2000, Development.

[17]  R. Simó,et al.  Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy , 1997, Diabetologia.

[18]  Joan W. Miller,et al.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. , 1994, American journal of ophthalmology.

[19]  J M Ward,et al.  Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Williamson,et al.  Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. , 1997, The Journal of clinical investigation.

[21]  K. Skorecki,et al.  Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy. , 2000, Diabetes care.

[22]  P. Campochiaro,et al.  Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. , 2000, The American journal of pathology.

[23]  R. Schwartz,et al.  Effects of diabetic pregnancy on the fetus and newborn. , 2000, Seminars in perinatology.

[24]  B. Gallacher,et al.  Glucose-Induced Protein Kinase C Activation Regulates Vascular Permeability Factor mRNA Expression and Peptide Production by Human Vascular Smooth Muscle Cells In Vitro , 1997, Diabetes.

[25]  J. Isner,et al.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. , 1999, The American journal of pathology.

[26]  H. Nishigori,et al.  Hepatocyte Growth Factor in Vitreous Fluid of Patients With Proliferative Diabetic Retinopathy and Other Retinal Disorders , 1998, Diabetes Care.

[27]  M. S. Lee,et al.  Hypoglycemia-induced VEGF expression is mediated by intracellular Ca2+ and protein kinase C signaling pathway in HepG2 human hepatoblastoma cells. , 2001, International journal of molecular medicine.

[28]  M. Goldberg,et al.  Hypoxia-inducible Protein Binding to Vascular Endothelial Growth Factor mRNA and Its Modulation by the von Hippel-Lindau Protein* , 1996, The Journal of Biological Chemistry.

[29]  R. Bucala,et al.  A Role for DNA Mutations in Diabetes-Associated Teratogenesis in Transgenic Embryos , 1995, Diabetes.

[30]  B. Shilo,et al.  Insulin induces transcription of target genes through the hypoxia‐inducible factor HIF‐1α/ARNT , 1998, The EMBO journal.

[31]  J. Winer,et al.  Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. , 1994, The Journal of biological chemistry.

[32]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Lois E. H. Smith,et al.  Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. , 1996, Archives of ophthalmology.

[34]  T. Yagi,et al.  A requirement for neuropilin-1 in embryonic vessel formation. , 1999, Development.

[35]  D. Maglione.  Persico MG.Isolation of a human placenta cDNA coding for a potein related to the vascular premeability factor , 1991 .

[36]  Hidehiro Ishii,et al.  Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.

[37]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[38]  Shay Soker,et al.  Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.

[39]  M. Cooper,et al.  Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. , 1999, Diabetes.

[40]  G. Conn,et al.  Purification and Characterization of a Naturally Occurring Vascular Endothelial Growth Factor · Placenta Growth Factor Heterodimer (*) , 1995, The Journal of Biological Chemistry.

[41]  D. Cha,et al.  Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. , 2000, The Journal of endocrinology.

[42]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[43]  Y. Okada,et al.  Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. , 2000, Investigative ophthalmology & visual science.

[44]  J. Williamson,et al.  Role for heparin-binding growth factors in glucose-induced vascular dysfunction. , 1998, Diabetes.

[45]  D. Foreman,et al.  VEGF localisation in diabetic retinopathy , 1998, The British journal of ophthalmology.

[46]  A. Adamis,et al.  Insulin-induced vascular endothelial growth factor expression in retina. , 1999, Investigative ophthalmology & visual science.

[47]  G. Viglietto,et al.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[48]  E. Voest,et al.  Up-regulation of vascular endothelial growth factor production by iron chelators. , 1996, Cancer research.

[49]  Y. Dor,et al.  Ischemia-driven angiogenesis. , 1997, Trends in cardiovascular medicine.

[50]  A. Nagy,et al.  Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. , 2001, The American journal of pathology.

[51]  L. Lanting,et al.  Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. , 1997, The American journal of physiology.

[52]  Lois E. H. Smith,et al.  Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Isner,et al.  Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF). , 1998, VASA. Zeitschrift fur Gefasskrankheiten.

[54]  R. Folberg,et al.  Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. , 1996, The British journal of ophthalmology.

[55]  R. McCarter,et al.  Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. , 1990, Teratology.

[56]  G. Lip,et al.  Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. , 2000, Investigative ophthalmology & visual science.

[57]  S. K. Ellington.  Effects of excess glucose on mammalian post-implantation embryos. , 1997, The International journal of developmental biology.

[58]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[59]  L. Aiello,et al.  Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. , 1999, Diabetes.

[60]  J. Klekamp,et al.  Vascular endothelial growth factor expression is decreased in rat lung following exposure to 24 or 48 hours of hyperoxia: implications for endothelial cell survival. , 1998, Chest.

[61]  Dian Feng,et al.  Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.

[62]  A. Reichenbach,et al.  VEGF release by retinal glia depends on both oxygen and glucose supply , 2000, Neuroreport.

[63]  R. de Hertogh,et al.  Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor-alpha in vitro. , 1997, Development.

[64]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[65]  L. Baker,et al.  Diabetic embryopathy: a selective review of recent trends. , 1993, Journal of diabetes and its complications.

[66]  K Walsh,et al.  Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.

[67]  J. Isner,et al.  Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. , 1996, Circulation.

[68]  B. Ebert,et al.  Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. , 1995, The American journal of physiology.

[69]  K Walsh,et al.  Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. , 1996, Human gene therapy.